Isolation of bacteriophage and ESBL-producing Escherichia coli from downstream water samples and examination of phage lytic activity against ESBL-producing E. coli
Journal of Biological Methods · 30.06.2026 · e99010103
DOI: 10.14440/jbm.0436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Methods, online erschienen am 30.06.2026. Verfasst von Masooma Jawad Hussain und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Amid global health concerns, extended-spectrum beta-lactamase (ESBL)-producing bacteria create substantial resistance challenges to current antibiotics. ESBL-producing pathogens are resistant to many antibiotics, including first- to third-generation cephalosporins, monobactams, or other antibiotic classes. Therefore, healthcare relies on carbapenems and colistin as their last options. Alarmingly, resistance to these critical drugs is increasing, emphasizing the urgent need for contemporary solutions, such as phage therapy. Objective:To develop an integrated workflow for identification and phage susceptibility assessment of ESBL-producing E. coli from environmental water samples.
Methods
In this study, 15 downstream water samples were collected from five locations in Islamabad and Rawalpindi, including Nala Lai, Chattar Park, Shahdara, Nescom Hospital H-10, and G-10.
Results
Of these, 10 samples (66.67%) tested positive for Escherichia coli, while five (33.33%) were negative. All samples from Chattar Park were negative for E. coli. Screening via the double-disk synergy test and combination disk test identified four samples (26.66%) with ESBL-producing E. coli and six (40%) with non-ESBL-producing isolates. Bacteriophages were isolated from Nescom Hospital stream water using the double agar overlay method and purified with a 0.45 μm syringe filter. The phages exhibited lytic activity against ESBL-producing E. coli NLA-3, as indicated in spot test results, and their therapeutic potential was validated through reduction assays. The isolated phage NHE-1 shows promise as an alternative treatment for antibiotic-resistant infections.
Conclusion
Further studies are needed to expand its application to diverse bacterial strains and evaluate its clinical efficacy. Utilizing bacteriophages’ natural ability to target bacteria may provide sustainable, effective solutions to combat antibiotic resistance.
Zitieren
APA
Hussain, M. J., Abbas, Y., Gul, H., Gul, S., Komal, S., & Nawaz, E. (2026). Isolation of bacteriophage and ESBL-producing Escherichia coli from downstream water samples and examination of phage lytic activity against ESBL-producing E. coli. Journal of Biological Methods, 0(0), e99010103. https://doi.org/10.14440/jbm.0436
Vancouver
Hussain MJ, Abbas Y, Gul H, Gul S, Komal S, Nawaz E. Isolation of bacteriophage and ESBL-producing Escherichia coli from downstream water samples and examination of phage lytic activity against ESBL-producing E. coli. Journal of Biological Methods. 2026;0(0):e99010103. doi:10.14440/jbm.0436
BibTeX
@article{Hussain2026,
author = {Hussain, Masooma Jawad and Abbas, Yawar and Gul, Hadia and Gul, Sarah and Komal, Sumbal and Nawaz, Eid},
title = {Isolation of bacteriophage and ESBL-producing Escherichia coli from downstream water samples and examination of phage lytic activity against ESBL-producing E. coli},
journal = {Journal of Biological Methods},
year = {2026},
volume = {0},
number = {0},
pages = {e99010103},
doi = {10.14440/jbm.0436}
}
EUVIMED